Medical Ethics and Law Research Center, Shaheed Beheshti University of Medical Sciences, Tehran, Iran.
Cardiovascular Research Foundation of Southern California, Beverly Hills, CA, USA.
Sci Rep. 2023 Aug 28;13(1):14027. doi: 10.1038/s41598-023-39836-6.
Red blood cell distribution width (RDW) has been reported as a meaningful prognostic factor in various diseases. Our study compared patients' RDW levels and prognosis at admission and discharge time. A total of 128 patients 77 patients who suffered brain death (subject group), and 51 patients who were discharged from the hospital (control group) with GCS ≤ 6 were recruited from 60 hospitals for this study. Demographical data and RDW measurements in these patients at admission time and brain death/discharge time were extracted into two groups. 46 (35.9%) patients were females and 82 patients (64.1%) were males with a median age of 36 years old. A significant difference in baseline characteristics of GCS (P < 0.001), RDW at admission time (P < 0.001), and RDW at discharge or brain death time (P < 0.001) were noted between the two groups. In the overall population, RDW at admission time had a median value of 13.75% and was positively correlated with gender (P < 0.04, rs = 0.582) and age (P < 0.023, rs = - 0.201). Initially, there were no significant differences in RDW upon admission. However, upon discharge, although the RDW in the control group was not significant (P < 0. 1), the RDW level at the time of brain death was notably 0.45 fold higher (P = 0.001) compared to the time of admission. The standardized residuals at the two-time points showed an approximately normal distribution. The most effective RDW cut-off in Brain death was determined as 14.55. Based on the findings, using RDW as a prognostic factor has a sensitivity of 0.468 and a specificity of 0.137 in diagnosing brain death. RDW biomarker is a simple and inexpensive laboratory test that may be seen as a valuable perspective for initial patient evaluation. RDW is a powerful marker for the prognosis of brain death in patients with a GCS ≤ 6 at admission time, in order to identify a subset of patients who may require more aggressive management in the trauma center.
红细胞分布宽度(RDW)已被报道为各种疾病有意义的预后因素。我们的研究比较了患者入院时和出院时的 RDW 水平和预后。这项研究共招募了 128 名患者,其中 77 名患者患有脑死亡(观察组),51 名患者从医院出院(对照组),格拉斯哥昏迷量表(GCS)评分均≤6。从 60 家医院提取这些患者入院时和脑死亡/出院时的人口统计学数据和 RDW 测量值,并将其分为两组。观察组 46 名(35.9%)为女性,82 名(64.1%)为男性,中位年龄为 36 岁。两组间 GCS (P<0.001)、入院时 RDW (P<0.001)和出院或脑死亡时 RDW (P<0.001)的基线特征差异有统计学意义。在总体人群中,入院时 RDW 的中位数为 13.75%,与性别(P<0.04,rs=0.582)和年龄(P<0.023,rs=-0.201)呈正相关。入院时 RDW 无显著差异。然而,出院时,尽管对照组的 RDW 无显著差异(P<0.1),但脑死亡时的 RDW 水平显著升高(P=0.001),与入院时相比升高了 0.45 倍。两个时间点的标准化残差呈近似正态分布。脑死亡最有效的 RDW 截断值为 14.55。研究结果表明,将 RDW 作为预后因素,诊断脑死亡的敏感性为 0.468,特异性为 0.137。RDW 标志物是一种简单且廉价的实验室检测,可能是初步患者评估的一个有价值的角度。RDW 是入院时 GCS 评分≤6 的脑死亡患者预后的有力标志物,有助于识别出创伤中心需要更积极治疗的亚组患者。